 |
|
General Warehousing Area
|
Most companies have one area devoted to receiving and storing
raw materials and another one dedicated to storing and shipping
products that have been approved by the QC - Batch Release
department. Precautions are taken to ensure the identity and
"status" (e.g., approved or not approved) of all items.
Also, storage conditions are important so temperature-sensitive
chemicals and drugs are not adversely affected.
Example of a GMP expectation that applies to Receiving and Shipping
Raw materials, components, packaging
materials, work-in-process, and finished products are stored under
conditions that contribute to their safety, identity, strength,
purity, and quality.
Example of GMP requirements specific to this GMP expectation
U.S.
-
Written procedures describing the
warehousing of drug products shall be established and
followed. They shall include: Storage of drug products under
appropriate conditions of temperature, humidity, and light so
that the identity, strength, quality, and purity of the drug
products are not affected. [211.142(b)]
-
There shall be written procedures describing
in sufficient detail the receipt, identification, storage,
handling, sampling, testing, and approval or rejection of
components and drug product containers and closures; such
written procedures shall be followed. [211.80(a)]
Canada
-
Raw materials, packaging materials,
intermediates, bulk drugs and finished products are (a) stored
in locations separate and removed from immediate manufacturing
areas, and (b) transported under conditions designated by the
quality control department to preserve their quality and
safety. [C.02.011 #48]
European Union
-
Storage areas should be designed or adapted
to ensure good storage conditions. In particular, they should
be clean and dry and maintained within acceptable temperature
limits. Where special storage conditions are required (e.g.
temperature, humidity) these should be provided, checked and
monitored. [EU # 3.19]
|